The aim of the present investigation was to develop and evaluate gastroretentive drug delivery tablets (GRDDTs) of ofloxacin using different polymers such as HPMC K4M, HPMC K15M, Polyethylene oxide WSR 303, Carbopol 971P, Xanthan Gum in different ratios for local action in gastric region to eradicate Helicobacter pylori infection. The GRDDTs were prepared by wet granulation method and evaluated for physical characteristics such as hardness, thickness, friability, drug content and floating properties. The optimized formula F4 showed better sustained drug release and which also had good floating properties and fitted best to be Korsmeyer-Peppas model with R 2 value of 0.9848. As the n value for the Korsmeyer-Peppas model was found be less than 0.45 it follows Fickian diffusion mechanism. FT-IR result showed that there is no drug excipient interaction. In vivo radiographic studies were conducted with BaSO4 loaded tablets to examine the increased gastric residence time of the prepared tablets. The study revealed that the tablet remained in the stomach for 300±10min which indicates the increase in the gastric residence time for the effective localized action of the ofloxacin in the treatment of Helicobacter pylori caused peptic ulcer.
INTRODUCTION
Over the past three decades the oral controlled release dosage forms have been developed due to their significant advantages such as patient compliance, ease of administration and flexibility in formulation. There are several difficulties in this approach such as inability to restrain and locate the controlled drug delivery system within the desired region of gastro intestinal tract due to gastric motility and gastric emptying which leads to reduced efficacy of the administered dosage (Rouge et al., 1996) . To overcome these problems oral controlled dosage form with gastro retentive properties were developed (Streubel et al., 2006) . Gastroretentive dosage forms are suitable for local drug delivery to the stomach and small intestine (Ali et al., 2005) . In case of many drugs which are released in the stomach have the greatest therapeutic effect while their release is prolonged in a continuous and controlled manner. This type of drug delivery system will have relatively less side effect and removes the need of repeated dosages (Hwang et al., 1998) .
Various approaches are available to increase gastric residence time of oral dosage form in the stomach which includes floating systems (Deshpande et al., 1997) , swelling and expanding systems (Urquhart and Theeuwes., 1984) , bioadhesive systems (Alvisi et al., 1996) , modified shape systems (Cargill et al., 1988) , high density systems (Bechgaard and Ladefoged., 1978) and other delayed gastric emptying devices (Groning and Heun., 1989; Groning and Heun., 1984) . The buoyant preparation increases gastric residence time of dosage form and also gives sustain release (Sing and Kim., 2000) . Based on the mechanism of buoyancy, two types of technologies are developed in the floating systems. They are non effervescent and effervescent systems. Non effervescent systems prepared by using polyacrylate, polycarbonate, polystyrene as excipients swells unrestrained via inhibition of gastric fluid to an extent which will prevent their exit from stomach (Garg and Gupta., 2008) . Effervescent system utilizes matrices prepared by using swellable polymers like methocel, polysaccharides and effervescent compounds like sodium bicarbonate, citric acid or tartaric acid (Rubinstein and Friend., 1994) .
Drugs suitable for floating drug delivery system includes drugs with narrow absorption window in GI tract, drugs which are mostly absorbed from stomach and upper part of GIT, drugs that act locally in the stomach, drugs that degrades in the colon, drugs which have poor solubility at alkaline pH. Several factors influence the gastric retention time of dosage forms such as density, size, shape, single or multiple unit formulation , nature of meal, caloric content, frequency of feed (Mazer et al.,1998; Agyilirah et al., 1991; Sangekar et al., 1987; Muller-Lissner et al., 1981; Oth et al., 1992; Moore et al., 1984; Mojaverian et al., 1985) , gender, age, posture (Mojaverian et al., 1988) .
Ofloxacin is a flouroquinolone, broad spectrum antibiotic, rapidly well absorbed from the gastrointestinal tract. Half life of ofloxacin is 9 hours and is used in the treatment of gentio urinary, respiratory, gastrointestinal, skin and soft tissue infections. Boldhane and Kuchekar., (2009) developed a gastroretentive drug delivery systems of metformin hydrochloride. Their study has shown that the metformin gastroretentive tablets prepared using sodium alginate and sodium carboxy methylcellulose can successfully be employed as a once a day oral controlled release drug delivery system. Jagadale et al., (2009) developed a gastroretentive drug delivery system of propranolol hydrochloride. Their investigation indicated that the tablets formulated using HPC, sodium alginate, HPMC E15 LV failed to produce matrix of required strength, while formulation containing xanthan gum showed good drug retaining abilities but floating abilities were found to be poor. Finally, floating tablets were formulated with HPMC K4M and HPC. Gambhire et al., (2007) formulated a floating drug delivery system of diltiazem hydrochloride using polymers such as hydroxypropyl methyl cellulose K100M CR and compritol 888 ATO, alone and in combination. They have investigated the effect of sodium bicarbonate and succinic acid on drug release. The high level of both methocel K100M CR and compritol 888 ATO favored the preparation of floating controlled release of diltiazem tablets. They have observed that incorporation of succinic acid in the formulation nullified the effect of the acidic dissolution media on the drug release in that formulation, methocel K100M CR retards the release by diffusion mechanism and compritol 888 ATO decreases the hydration of matrix and retards the release by erosion mechanism owing to its hydrophobic property. Together, these polymers retard the release of drug using different mechanisms. Mahesh et al., (2006) reported Novel sustained release, swellable and bioadhesive gastro retentive drug delivery system for ofloxacin. Mahesh et al., (2005) proposed a new strategy for the development of gastroretentive dosage forms for ofloxacin preferably once daily. The design of the delivery system was based on the sustained release formulation, with floating and swelling features in order to prolong the gastric retention time of the drug delivery systems. They tried different polymers, such as psyllium husk, HPMC K100M, crospovidone and its combinations in order to get the desired sustained release profile over a period of 24 hours. They found that in vitro drug release rate increased with increasing amount of crospovidone due to the increased water uptake, and hence increased driving force for drug release.
MATERIALS AND METHODS
Ofloxacin was a generous gift sample from Ranbaxy Laboratories Ltd, Gurgaon New Delhi, India. Polyethylene oxide WSR 303 was gift sample from Ra Chem Pharma Ltd, Hyderabad, India. Hydroxy propyl methyl cellulose (HPMC K4M and HPMC K100M), Carbopol 971P, xanthan gum and Avicel 112 were gifted by Orchid Health Care Pvt Ltd, Chennai, India. All other chemicals used were of analytical grade.
Preparation Method of Ofloxacin Floating Tablets
Drug, polymer and sodium bicarbonate were weighed and passed through sieve with mesh #40 and were mixed homogeneously in a polybag for about 5-10 mins and was taken in a mortar. 5% PVP K30 in isopropyl alcohol was used as granulating agent. The wet mass was passed through mesh #14 and dried in hot air oven at 50°C for 30 mins. and dried granules were sieved through mesh #16. Finally well formed granules were lubricated with magnesium stearate and talc. Formulation compositions of all batches were shown in Table 1 .
Evaluation of Floating Tablets
The prepared floating tablets were evaluated for hardness, thickness and friability which were measured by a hardness tester (Monsanto, Germany), vernier calipers (Mitutoyo Corporation, Japan) and friability test apparatus (Campbell Electronics friabilator, India) respectively. The drug content in each formulation was determined by triturating ten tablets in a mortar and amount equivalent to one average tablet was accurately weighed and dissolved in 100ml 0.1 N HCl taken in a 250 ml volumetric flask. The flask was kept on mechanical shaker for overnight, later was filtered through a filter paper and the first few ml were discarded. The filtrate was sufficiently diluted and the absorbance was recorded against the blank at 293 nm using UV-Visible spectrophotometer.
In vitro buoyancy studies
The in vitro buoyancy was determined by floating lag time and floating duration in a 100 ml glass beaker containing 0.1N HCl.
In vitro drug release studies
The in vitro drug release study was conducted using the USP dissolution apparatus-II (paddle method) and 900ml of 0.1N HCl (pH 1.2) as dissolution release medium. The study was conducted at 37 ± 0.5°C and at paddle rotation of 50 rpm. The tablet was placed inside the dissolution vessel. 5ml of sample were withdrawn at predetermined time intervals of 0.5, 1, 2, 3, 4, 6, 8, 10 and 12 hours. The volume of dissolution fluid was adjusted to 900 ml by replacing 5ml of fresh dissolution medium after each sampling. The release studies were performed in triplicate, and the mean values were plotted versus time. Each sample was analyzed at 293nm using double beam UVVisible Spectrophotometer against reagent blank.
Drug release kinetics
Various models were tested for explaining the kinetics of drug release. To analyze the mechanism of the drug release rate kinetics of the dosage form, the obtained data were fitted into zero-order (Donbrow et al., 1980) , first order (Merchant et al., 2006) , Higuchi (Higuchi T., 1963) and Korsmeyer-Peppas (Korsmeyer et al., 1983) release model.
Fourier Transform Infrared Spectroscopy Studies
Fourier transform infrared spectra of the ofloxacin pure drug, polymer, physical mixture of drug and excipients and placebo were obtained using Fourier Transform Infrared Spectrophotometer (Bruker Model: Alpha-T, Ettlingen, Germany). Samples were prepared using KBr disks by means of hydraulic pellet press at a pressure of 7-10 tons. The samples were scanned from 4000 to 400cm -1 .
In vivo confirmation of buoyancy by using radiographic studies For this study the tablets of optimized batch (F4) were prepared by replacing half of the amount of drug with barium sulfate. After overnight fasting of three healthy volunteers they were fed with low calorie food and allowed to take water after these tablets were administered orally. Radiographs were obtained at predetermined time intervals (1hr., 2hrs., 3 hrs. and 5hrs.). The Institutional Human Ethical Committee approved the protocol for this study. Physical mixture of optimized formulation 
RESULT AND DISCUSSION

Evaluation of floating tablets
All formulations were tested for physical parameters like hardness, thickness, weight variation, and friability and results were shown in Table 2 . The best formulation (F4) showed hardness of 5.0 ± 0.1kg/cm 2 , thickness of 5.56 ± 0.05 mm, friability of 0.29% and the drug content of all the formulations was determined and was found to be within the permissible limit and in vitro floating evaluation parameters were showed in Table 3 .
As the amount of HPMC K4M decreased, TFT decreased probably because of the poor gelling strength. In the case of HPMC K15M and PEO, TFT increased this is because of increased gel strength of matrices which prevents escape of evolved CO2 from matrices, leading to decreased density. As the amount of carbopol 971P increased, TFT decreased which may be due to high affinity of carbopol towards water, which promotes water penetration into tablet matrices, leading to increased density. Xanthan Gum will have the nature of high viscosity therefore sodium bicarbonate takes more time to react with dissolution medium which leads to increase in the floating lag time.
In vitro drug release studies
In vitro drug release profile for all prepared formulations were depicted in Figure 1 . The formulations containing HPMC K4M showed poor integrity. Further attempt were made to improve the integrity by increasing the polymer percentage but were unable to show the desired integrity within the highest possible concentration of the polymer in the formulation. The formulation F1 which contain least (10%) amount of polymer showed drug release to the extent of 96.18% within 4 hours. When the polymer concentration is increased to 20% of total weight of the tablet (F2), 96.49% of drug release was achieved within 6 hours. Further increment of the polymer to 30% (F3) has resulted in 95.68% of drug release in 8 hours.
The formulations containing HPMC K15M have shown sustaining effect on the release of drug from the floating matrix tablets, but the increase in the concentration of the same polymer in the formulation retards the release of drug from the tablet. Formulation F4 gave the best results which retarded the drug release 98.80% for 12hours and hence it was considered as the optimized formulation. The formulation F5 had drug release of 83.69% in 12hours and F6 had drug release of 73.01% in 12 hours. The formulations which contain PEO show retarded effect on drug release with the increase in the polymer ratio. The formulation F7 which contain polymer ratio 10% of total tablet weight dissolved in the dissolution medium at about 8 hours.
With other formulations the tablet floated more than 12hours. The formulations which contain carbopol showed retarded effect on drug release when there was increase in the polymer ratio. However, it has a disadvantage where increase in the polymer ratio leads to decrease in the floating time which is due to increase in the density. Xanthan gum has sustaining effect on the release of drug from the floating matrix tablets but the increase in the concentration of the same polymer in the formulation retards the release of drug from the tablet. The release of drug from all formulation was less than 55% within 12 hours.
Drug Release Kinetics
Regression coefficient value (R 2 ) and n values for all formulation were shown in Table 4 . The release profile of optimized formula F4, fitted best to Korsmeyer-Peppas model with R 2 value of 0.9848. As the n value for the KorsmeyerPeppas model was found to be less than 0.45 it follows Fickian diffusion mechanism.
Fourier Transform Infrared Spectroscopy Studies FTIR spectra and Characteristic peaks for pure drug, polymer, physical mixture of optimized formulation, and placebo were represented in Figure 2 and Table 5 respectively. Pure drug characteristic peaks were observed in pure drug and physical mixture of optimized formulation only but not in pure polymer and placebo. Polymer chrematistic peaks were observed in polymer, physical mixture of optimized formulation and placebo. Therefore, from this FTIR study can be concluding that the pure drug has no interaction with excipients.
